Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Laboratorios Farmaceuticos Rovi, S.A.

Market Cap 2.97B 3.4B 2.75B 2.57B 4.82B 321B 4.85B 32.6B 12.63B 158B 12.77B 12.5B 549B P/E 2026 *
22.2x
P/E 2027 * 16.3x
Enterprise Value 2.94B 3.38B 2.73B 2.55B 4.79B 319B 4.82B 32.35B 12.54B 157B 12.68B 12.4B 545B EV / Sales 2026 *
3.8x
EV / Sales 2027 * 3.15x
Free-Float
31.63%
Yield 2026 *
1.68%
Yield 2027 * 2.02%
1 day-0.77%
1 week+0.17%
Current month-2.18%
1 month-0.34%
3 months-27.50%
6 months-5.44%
Current year-7.98%
1 week 58.1
Extreme 58.1
59.3
1 month 57.4
Extreme 57.4
61
Current year 57.4
Extreme 57.4
86.6
1 year 51.85
Extreme 51.85
86.6
3 years 38.38
Extreme 38.38
90.75
5 years 35.64
Extreme 35.64
90.75
10 years 35.64
Extreme 35.64
90.75
Manager TitleAgeSince
Chief Executive Officer - 26/07/2007
Director of Finance/CFO - 31/12/2000
Chief Tech/Sci/R&D Officer - 31/12/2013
Director TitleAgeSince
Chairman - 16/07/2021
Director/Board Member - 26/07/2007
Director/Board Member - 26/07/2007
Change 5-day change 1-year change 3-year change Capi.($)
-0.77%+0.17% - - 3.42B
-1.21%-5.37%+39.94%+145.38% 980B
-2.48%-4.17%+51.52%+39.07% 550B
-2.14%-3.68%+16.71%+56.15% 382B
-1.75%+0.25%+25.86%+16.53% 317B
+0.61%-2.53%+25.46%+12.27% 270B
+0.22%-2.67%+24.57%+30.34% 269B
+4.59%+3.68%-39.28%-46.92% 191B
-1.19%-4.65%+16.56%+47.00% 182B
-1.35%-1.68%+14.59%+56.94% 154B
Average -0.53%-2.68%+19.55%+39.64% 366B
Weighted average by Cap. -0.97%-3.38%+28.32%+63.89%

Financials

2026 *2027 *
Net sales 774M 888M 717M 671M 1.26B 83.77B 1.27B 8.5B 3.3B 41.23B 3.33B 3.26B 143B 913M 1.05B 846M 792M 1.48B 98.82B 1.49B 10.03B 3.89B 48.64B 3.93B 3.85B 169B
Net income 133M 153M 123M 115M 216M 14.39B 218M 1.46B 566M 7.08B 573M 560M 24.6B 183M 209M 169M 158M 297M 19.76B 299M 2.01B 777M 9.73B 786M 769M 33.77B
Net Debt -22.53M -25.84M -20.87M -19.54M -36.64M -2.44B -36.86M -248M -95.95M -1.2B -97.01M -94.93M -4.17B -90.52M -104M -83.84M -78.48M -147M -9.8B -148M -995M -385M -4.82B -390M -381M -16.74B
Logo Laboratorios Farmaceuticos Rovi, S.A.
Laboratorios Farmaceuticos Rovi, S.A. specializes in the research, development, manufacturing and marketing of biological medications and specialty drugs. Net sales break down by family of products as follows: - prescription pharmaceuticals (49%): intended for preventing and treating venous thrombo-embolic disease, post-menopausal osteoporosis, muscle pain, tooth and mouth infections, angina, osteoarthritis, etc.; - pharmaceutical products manufactured under contract (44%); - diagnostic products (7%): contrast products used in medical imaging with magnetic resonance, ultrasound, or X-rays. The group also offers hospital products and non-prescription pharmaceuticals. Net sales break down by source of revenue between sales of products (95.4%) and sales of services (4.6%). Net sales are distributed geographically as follows: Spain (77%), Italy (5%), Germany (3%), Portugal (2%), France (1%), Greece (1%) and other (11%).
Employees
1,998
Date Price Change
18/06/26 58.25 -0.09%
18/06/26 58.30 -0.77%
17/06/26 58.75 +0.60%
16/06/26 58.40 -0.17%
15/06/26 58.50 -0.09%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
58.30EUR
Average target price
75.38EUR
Spread / Average Target
+29.29%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!